{"entity":{"type":"insider","cik":"0001704483","url":"/insider/0001704483","json_url":"/insider/0001704483.json","name":"Berman Robert","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":78,"n_filings":17,"first":"2017-05-11","last":"2020-07-10","span_basis":"filed_date"},"name_variants":[{"name":"Berman Robert","source":"filing","n_filings":17,"first_seen":"2017-05-11","last_seen":"2020-07-10"}],"transactions":[{"id":2201805,"accession":"0001562180-20-005100","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-20-005100","line_url":"/filing/0001562180-20-005100","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704483","owner_name":"Berman Robert","owner_display_name":"Berman Robert","owner_url":"/insider/0001704483","role":"Officer (Special Projects & Med Ovrsght)","role_mark":"O","role_mark_label":"Officer (Special Projects & Med Ovrsght)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Special Projects & Med Ovrsght","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58404.0,"shares_display":"58,404","price_per_share":75.2498074789398,"price_display":"75.25","price_state":"stated","total_value":4394889.756,"total_display":"4,394,889.76","total_whole":"4,394,890","shares_owned_after":3119.0,"shares_owned_after_display":"3,119","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-08","filed_date":"2020-07-10","scope":"insider","n_lines":2},{"id":2946962,"accession":"0001562180-20-004697","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-004697","line_url":"/filing/0001562180-20-004697#line-2","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704483","owner_name":"Berman Robert","owner_display_name":"Berman Robert","owner_url":"/insider/0001704483","role":"Officer (Special Projects & Med Ovrsght)","role_mark":"O","role_mark_label":"Officer (Special Projects & Med Ovrsght)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Special Projects & Med Ovrsght","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4296.0,"shares_display":"4,296","price_per_share":75.0538,"price_display":"75.05","price_state":"stated","total_value":322431.1248,"total_display":"322,431.12","total_whole":"322,431","shares_owned_after":341.0,"shares_owned_after_display":"341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-23","filed_date":"2020-06-25","scope":"insider"},{"id":2316583,"accession":"0001562180-20-004627","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001562180-20-004627","line_url":"/filing/0001562180-20-004627#line-6","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704483","owner_name":"Berman Robert","owner_display_name":"Berman Robert","owner_url":"/insider/0001704483","role":"Officer (Special Projects & Med Ovrsght)","role_mark":"O","role_mark_label":"Officer (Special Projects & Med Ovrsght)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Special Projects & Med Ovrsght","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":986.0,"shares_display":"986","price_per_share":75.0669,"price_display":"75.07","price_state":"stated","total_value":74015.9634,"total_display":"74,015.96","total_whole":"74,016","shares_owned_after":341.0,"shares_owned_after_display":"341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-19","filed_date":"2020-06-22","scope":"insider"},{"id":2316572,"accession":"0001562180-20-004627","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-20-004627","line_url":"/filing/0001562180-20-004627","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704483","owner_name":"Berman Robert","owner_display_name":"Berman Robert","owner_url":"/insider/0001704483","role":"Officer (Special Projects & Med Ovrsght)","role_mark":"O","role_mark_label":"Officer (Special Projects & Med Ovrsght)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Special Projects & Med Ovrsght","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61314.0,"shares_display":"61,314","price_per_share":75.27301364451839,"price_display":"75.27","price_state":"stated","total_value":4615289.5586,"total_display":"4,615,289.56","total_whole":"4,615,290","shares_owned_after":1741.0,"shares_owned_after_display":"1,741","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-18","filed_date":"2020-06-22","scope":"insider","n_lines":2},{"id":7819052,"accession":"0001562180-19-006296","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001562180-19-006296","line_url":"/filing/0001562180-19-006296","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704483","owner_name":"Berman Robert","owner_display_name":"Berman Robert","owner_url":"/insider/0001704483","role":"Officer (Special Projects & Med Ovrsght)","role_mark":"O","role_mark_label":"Officer (Special Projects & Med Ovrsght)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Special Projects & Med Ovrsght","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":125000.0,"shares_display":"125,000","price_per_share":53.2164199408,"price_display":"53.22","price_state":"stated","total_value":6652052.4926,"total_display":"6,652,052.49","total_whole":"6,652,052","shares_owned_after":57891.0,"shares_owned_after_display":"57,891","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-30","filed_date":"2019-12-31","scope":"insider","n_lines":4},{"id":8298276,"accession":"0001209191-19-039411","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-039411","line_url":"/filing/0001209191-19-039411#line-1","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704483","owner_name":"Berman Robert","owner_display_name":"Berman Robert","owner_url":"/insider/0001704483","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":42.3,"price_display":"42.30","price_state":"stated","total_value":105750.0,"total_display":"105,750.00","total_whole":"105,750","shares_owned_after":240500.0,"shares_owned_after_display":"240,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-27","filed_date":"2019-06-28","scope":"insider"},{"id":9270667,"accession":"0001209191-18-038886","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-038886","line_url":"/filing/0001209191-18-038886","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704483","owner_name":"Berman Robert","owner_display_name":"Berman Robert","owner_url":"/insider/0001704483","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16276.0,"shares_display":"16,276","price_per_share":37.391637380191696,"price_display":"37.39","price_state":"stated","total_value":608586.29,"total_display":"608,586.29","total_whole":"608,586","shares_owned_after":249629.0,"shares_owned_after_display":"249,629","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-12","filed_date":"2018-06-20","scope":"insider","n_lines":2},{"id":6291871,"accession":"0001209191-18-037215","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-18-037215","line_url":"/filing/0001209191-18-037215","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704483","owner_name":"Berman Robert","owner_display_name":"Berman Robert","owner_url":"/insider/0001704483","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20257.0,"shares_display":"20,257","price_per_share":37.391645850817,"price_display":"37.39","price_state":"stated","total_value":757442.57,"total_display":"757,442.57","total_whole":"757,443","shares_owned_after":240180.0,"shares_owned_after_display":"240,180","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-12","filed_date":"2018-06-12","scope":"insider","n_lines":4},{"id":9270666,"accession":"0001209191-18-038886","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-038886","line_url":"/filing/0001209191-18-038886","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704483","owner_name":"Berman Robert","owner_display_name":"Berman Robert","owner_url":"/insider/0001704483","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60416.0,"shares_display":"60,416","price_per_share":36.08514797404661,"price_display":"36.09","price_state":"stated","total_value":2180120.3,"total_display":"2,180,120.30","total_whole":"2,180,120","shares_owned_after":260276.0,"shares_owned_after_display":"260,276","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-11","filed_date":"2018-06-20","scope":"insider","n_lines":3},{"id":6291859,"accession":"0001209191-18-037215","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-18-037215","line_url":"/filing/0001209191-18-037215","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704483","owner_name":"Berman Robert","owner_display_name":"Berman Robert","owner_url":"/insider/0001704483","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75492.0,"shares_display":"75,492","price_per_share":36.08541408361151,"price_display":"36.09","price_state":"stated","total_value":2724160.08,"total_display":"2,724,160.08","total_whole":"2,724,160","shares_owned_after":250927.0,"shares_owned_after_display":"250,927","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-11","filed_date":"2018-06-12","scope":"insider","n_lines":5},{"id":6291839,"accession":"0001209191-18-037215","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-037215","line_url":"/filing/0001209191-18-037215","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704483","owner_name":"Berman Robert","owner_display_name":"Berman Robert","owner_url":"/insider/0001704483","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8406.0,"shares_display":"8,406","price_per_share":36.01,"price_display":"36.01","price_state":"stated","total_value":302700.06,"total_display":"302,700.06","total_whole":"302,700","shares_owned_after":320692.0,"shares_owned_after_display":"320,692","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-08","filed_date":"2018-06-12","scope":"insider","n_lines":2},{"id":6725931,"accession":"0001209191-18-036358","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-18-036358","line_url":"/filing/0001209191-18-036358","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704483","owner_name":"Berman Robert","owner_display_name":"Berman Robert","owner_url":"/insider/0001704483","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":36.01,"price_display":"36.01","price_state":"stated","total_value":90025.0,"total_display":"90,025.00","total_whole":"90,025","shares_owned_after":327427.0,"shares_owned_after_display":"327,427","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-07","filed_date":"2018-06-07","scope":"insider","n_lines":2},{"id":6725926,"accession":"0001209191-18-036358","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-036358","line_url":"/filing/0001209191-18-036358","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704483","owner_name":"Berman Robert","owner_display_name":"Berman Robert","owner_url":"/insider/0001704483","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16983.0,"shares_display":"16,983","price_per_share":36.01,"price_display":"36.01","price_state":"stated","total_value":611557.83,"total_display":"611,557.83","total_whole":"611,558","shares_owned_after":329430.0,"shares_owned_after_display":"329,430","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-06","filed_date":"2018-06-07","scope":"insider","n_lines":2},{"id":6725920,"accession":"0001209191-18-036358","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-036358","line_url":"/filing/0001209191-18-036358","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704483","owner_name":"Berman Robert","owner_display_name":"Berman Robert","owner_url":"/insider/0001704483","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6362.0,"shares_display":"6,362","price_per_share":36.015598868280414,"price_display":"36.02","price_state":"stated","total_value":229131.24,"total_display":"229,131.24","total_whole":"229,131","shares_owned_after":343038.0,"shares_owned_after_display":"343,038","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-05","filed_date":"2018-06-07","scope":"insider","n_lines":2},{"id":6495042,"accession":"0001209191-18-029912","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-029912","line_url":"/filing/0001209191-18-029912","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704483","owner_name":"Berman Robert","owner_display_name":"Berman Robert","owner_url":"/insider/0001704483","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":26.820171428571427,"price_display":"26.82","price_state":"stated","total_value":938706.0,"total_display":"938,706.00","total_whole":"938,706","shares_owned_after":349520.0,"shares_owned_after_display":"349,520","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-10","filed_date":"2018-05-14","scope":"insider","n_lines":4},{"id":6133534,"accession":"0001209191-18-024757","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-18-024757","line_url":"/filing/0001209191-18-024757","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704483","owner_name":"Berman Robert","owner_display_name":"Berman Robert","owner_url":"/insider/0001704483","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":24.660914285714284,"price_display":"24.66","price_state":"stated","total_value":863132.0,"total_display":"863,132.00","total_whole":"863,132","shares_owned_after":386960.0,"shares_owned_after_display":"386,960","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-10","filed_date":"2018-04-12","scope":"insider","n_lines":6},{"id":6198641,"accession":"0001209191-18-019618","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-019618","line_url":"/filing/0001209191-18-019618","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704483","owner_name":"Berman Robert","owner_display_name":"Berman Robert","owner_url":"/insider/0001704483","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":30.112257142857143,"price_display":"30.11","price_state":"stated","total_value":1053929.0,"total_display":"1,053,929.00","total_whole":"1,053,929","shares_owned_after":406360.0,"shares_owned_after_display":"406,360","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-12","filed_date":"2018-03-14","scope":"insider","n_lines":4},{"id":6821372,"accession":"0001209191-18-009971","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-009971","line_url":"/filing/0001209191-18-009971#line-4","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704483","owner_name":"Berman Robert","owner_display_name":"Berman Robert","owner_url":"/insider/0001704483","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18544.0,"shares_display":"18,544","price_per_share":30.69,"price_display":"30.69","price_state":"stated","total_value":569115.36,"total_display":"569,115.36","total_whole":"569,115","shares_owned_after":432000.0,"shares_owned_after_display":"432,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-12","filed_date":"2018-02-14","scope":"insider"},{"id":6821367,"accession":"0001209191-18-009971","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-009971","line_url":"/filing/0001209191-18-009971#line-3","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704483","owner_name":"Berman Robert","owner_display_name":"Berman Robert","owner_url":"/insider/0001704483","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9456.0,"shares_display":"9,456","price_per_share":29.88,"price_display":"29.88","price_state":"stated","total_value":282545.28,"total_display":"282,545.28","total_whole":"282,545","shares_owned_after":450544.0,"shares_owned_after_display":"450,544","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-12","filed_date":"2018-02-14","scope":"insider"},{"id":6821355,"accession":"0001209191-18-009971","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-009971","line_url":"/filing/0001209191-18-009971#line-2","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704483","owner_name":"Berman Robert","owner_display_name":"Berman Robert","owner_url":"/insider/0001704483","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4636.0,"shares_display":"4,636","price_per_share":30.69,"price_display":"30.69","price_state":"stated","total_value":142278.84,"total_display":"142,278.84","total_whole":"142,279","shares_owned_after":597000.0,"shares_owned_after_display":"597,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-12","filed_date":"2018-02-14","scope":"insider"}],"collapsed":true,"next_cursor":"2018-02-12|6821355","ledger_fault":false,"count":{"value":78,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":76,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":78},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001689813","name":"Biohaven Pharmaceutical Holding Co Ltd.","url":"/issuer/0001689813","role":"Officer (Special Projects & Med Ovrsght)","n_filings":17,"first_seen":"2017-05-11","last_seen":"2020-07-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001704483","retrieved_at":"2026-08-27T20:58:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}